Ravasio, Roberto, Silvia Antonelli, Alessia Maiorino, Antonio Costanzo, and Serena Losi. “Cost Per Responder for Ixekizumab and Other Biologic Drugs Approved for the Treatment of Moderate-to-Severe Plaque Psoriasis in Italy”. Global & Regional Health Technology Assessment 6, no. 1 (January 7, 2019). Accessed April 2, 2020. https://journals.aboutscience.eu/index.php/grhta/article/view/468.